Shanghai Simr Biotechnology Co., Ltd.

This study tested a new drug called SR750 in 138 people with trigeminal neuralgia, a condition that causes sudden, severe facial pain. Participants took either the study drug or a placebo for 6 weeks and recorded their daily pain levels. The goal was to see if SR750 could safely …

This early-stage study tested the safety and how the body processes a new drug called SR750 in 40 healthy Chinese adults aged 18 to 45. Participants received either the drug or a placebo, and researchers measured drug levels in the blood and monitored for side effects. The goal w…